marketsgonewild

Unpacking the Success of Nomad Foods Limited: A Recap of the Q3 2024 Earnings Call

Nomad Foods Limited (NYSE:NOMD) Q3 2024 Earnings Conference Call Company Participants: Jason English – Head of Investor Relations Stefan Descheemaeker – Chief Executive Officer Ruben Baldew – Chief Financial Officer Conference Call Participants: Andrew Lazar – Barclays Steve Powers – Deutsche Bank Rob Dickinson – Jefferies John Baumgartner – Mizuho Securities Jon Tanwanteng – CJS…

Read More

Important Shareholder Notice: Pomerantz Law Firm Reminds Investors of TMC – The Metals Company Inc. of Class Action Lawsuit and Upcoming Deadlines for Losses on Investments

The Impact of the TMC Metals Company Class Action Lawsuit Recently, Pomerantz LLP announced that a class action lawsuit has been filed against TMC the metals company Inc. (“TMC” or the “Company”) (NASDAQ:TMC) and certain officers. The lawsuit, filed in the United States District Court for the Central District Of California, on behalf of a…

Read More

Unleash the Power: Energy Plug Launches Revolutionary 20 kWh Decentralized Battery System for Cryptocurrency and AI Needs!

Welcome to the Future of Energy with Energy Plug Technologies Corp. A Game-Changer in the Energy Industry Vancouver, British Columbia–(Newsfile Corp. – November 14, 2024) – Energy Plug Technologies Corp. (CSE: PLUG) (OTCQB: PLGGF) (FSE: 6GQ) (“Energy Plug” or the “Company”) is pleased to announce the launch of its 20 kWh Decentralized Battery System. Designed…

Read More

Immutep’s Efti: The Cancer-Fighting Superhero – INSIGHT-003 Trial Results Revealed!

Immutep Limited Announces Positive Data from INSIGHT-003 Trial Mature Data Shows Excellent Results in NSCLC Patients Sydney, Australia, Nov. 14, 2024 (GLOBE NEWSWIRE) – Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company, has released positive data from the INSIGHT-003 Phase I trial. Immutep’s latest data from patients with a…

Read More

Palatin’s First Quarter Fiscal Year 2025 Operating and Financial Results: A Peek into the Future!

Palatin’s First Quarter Fiscal Year 2025 Operating and Financial Results: A Peek into the Future! Description: In the world of biopharmaceuticals, Palatin Technologies is making waves with its core focus on obesity programs. The company is delving into new territories with an exploratory co-administration BMT-801 study and two novel drug candidates in Phase 2 clinical…

Read More

Palantir Stock: A Rollercoaster Ride of AI Awesomeness, Q3 Earnings Surprises, and Ontology Advantages (But We’re Still Sticking with a ‘Hold’ Rating)

Welcome to my quirky corner of the internet! Let’s talk about Palantir’s strong revenue growth So, have you heard about Palantir’s recent success in the US government and commercial sectors? It seems like they are really on a roll with their AI solutions. I mean, who wouldn’t want to reduce manpower and processing times significantly?…

Read More

Doubleview Gold Corp Strikes Gold with Successful Private Placement – Raises $4.02 Million!

Welcome to the Doubleview Gold Corp. Private Placement Announcement! Exciting News for Doubleview Gold Corp. It’s always great to hear positive news coming from companies, and Doubleview Gold Corp. is no exception. The recent announcement of their successful non-brokered Private Placement of flow-through funds is definitely something to celebrate. With gross proceeds exceeding expectations, the…

Read More